Get the Weekly Intelligence Brief — top committee picks every Sunday.

MIRM vs PEN

Mirum Pharmaceuticals, Inc. vs Penumbra, Inc. — AI-powered side-by-side comparison
MIRM
Mirum Pharmaceuticals, Inc.
56
Watch
VS
PEN
Penumbra, Inc.
67
Buy
MetricMIRMPEN
AI Score 56 67
Price $98.27 $326.07
P/E Ratio -6.75× 79.78×
ROE -7.4% 12.4%
Revenue Growth YoY
Gross Margin 81.7% 67.8%
Debt / Equity -72.97× 0.14×
Dividend Yield 0.0% 0.0%
RSI (14) 33.9 79.6
Beta 0.507 0.701
Expected Upside +6.3%

AI Committee View

Current Innellis committee reasoning for MIRM versus PEN.
PEN leads by 11 points.

PEN scores 67/100 (Buy) versus MIRM at 56/100 (Watch).

MIRM Committee View
50% agreement
6 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 44.0% yoy -- genuine top-line momentum. Value Analyst remains cautious — price-to-book of 13.0x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Revenue growing 44.0% YoY -- genuine top-line momentum — Growth
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 13.0x prices in significant intangible value — Value
  • ROE of only -289.3% -- cheap may mean cheap for a reason — Value
  • MACD histogram negative -- bearish momentum — Technical
PEN Committee View
80% agreement
5 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is 2 consecutive earnings misses -- execution concerns. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • 2 consecutive earnings misses -- execution concerns — Growth
  • RSI at 80 is in overbought territory — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MIRM Full Analysis PEN Full Analysis